TABLE 3.
Relationship between ASNS, CEBPA, and CAD expression level and clinicopathological variables in 16 colon cancer patients.
| Pathological characteristics | n | Low expression (n) | High expression (n) | p value |
|---|---|---|---|---|
| Age(years) | 0.547 | |||
| ≥65 | 10 | 3 | 7 | |
| <65 | 6 | 4 | 2 | |
| Gender | 0.174 | |||
| M | 10 | 3 | 7 | |
| F | 6 | 4 | 2 | |
| Tumor size (cm) | 0.043 | |||
| ≥20 | 7 | 5 | 2 | |
| <20 | 9 | 2 | 7 | |
| TNM stage | 0.674 | |||
| T3N0Mx | 7 | 3 | 4 | |
| T3N1Mx | 7 | 3 | 4 | |
| T3N2Mx | 1 | 0 | 1 | |
| T4N1Mx | 1 | 1 | 0 | |
| Metastasis or recurrence within 3 years | 0.953 | |||
| Occurrence | 9 | 4 | 5 | |
| Not occurrence | 7 | 3 | 4 |
| Pathological characteristics | n | Low expression (n) | High expression (n) | p value |
|---|---|---|---|---|
| Age(years) | 0.156 | |||
| ≥65 | 10 | 3 | 7 | |
| <65 | 6 | 0 | 6 | |
| Gender | 0.01 | |||
| M | 10 | 0 | 10 | |
| F | 6 | 3 | 3 | |
| Tumor size (cm) | 0.409 | |||
| ≥20 | 7 | 2 | 5 | |
| <20 | 9 | 1 | 8 | |
| TNM stage | 0.034 | |||
| T3N0Mx | 7 | 0 | 7 | |
| T3N1Mx | 7 | 2 | 5 | |
| T3N2Mx | 1 | 0 | 1 | |
| T4N1Mx | 1 | 1 | 0 | |
| Metastasis or recurrence within 3 years | 0.102 | |||
| Occurrence | 9 | 3 | 6 | |
| Not occurrence | 7 | 0 | 7 |
| Pathological characteristics | n | Low expression (n) | High expression (n) | p value |
|---|---|---|---|---|
| Age(years) | 0.547 | |||
| ≥65 | 10 | 5 | 5 | |
| <65 | 6 | 2 | 4 | |
| Gender | 0.174 | |||
| M | 10 | 3 | 7 | |
| F | 6 | 4 | 2 | |
| Tumor size (cm) | 0.053 | |||
| ≥20 | 7 | 5 | 2 | |
| <20 | 9 | 2 | 7 | |
| TNM stage | 0.674 | |||
| T3N0Mx | 7 | 3 | 4 | |
| T3N1Mx | 7 | 3 | 4 | |
| T3N2Mx | 1 | 0 | 1 | |
| T4N1Mx | 1 | 1 | 0 | |
| Metastasis or recurrence within 3 years | 0.001 | |||
| Occurrence | 9 | 1 | 8 | |
| Not occurrence | 7 | 6 | 1 |